BDBM517778 (R)-1-(5- chloropyrazin-2-yl)- 3-(1-(4-(1- (morpholinomethyl) cyclopropyl) phenyl)-2- oxopiperidin-3- yl)urea::US11124494, Example 55

SMILES Clc1cnc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)C2(CN3CCOCC3)CC2)cn1

InChI Key InChIKey=PTJUGGVRIKDVSE-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 517778   

TargetN-formyl peptide receptor 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM517778(US11124494, Example 55 | (R)-1-(5- chloropyrazin-2...)
Affinity DataEC50: <10nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent